Your browser doesn't support javascript.
loading
Virological and Serological Characterisation of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 Vaccination Between December 2020 and March 2021.
Colavita, Francesca; Meschi, Silvia; Gruber, Cesare Ernesto Maria; Rueca, Martina; Vairo, Francesco; Matusali, Giulia; Lapa, Daniele; Giombini, Emanuela; De Carli, Gabriella; Spaziante, Martina; Messina, Francesco; Bonfiglio, Giulia; Carletti, Fabrizio; Lalle, Eleonora; Fabeni, Lavinia; Berno, Giulia; Puro, Vincenzo; Bartolini, Barbara; Di Caro, Antonino; Ippolito, Giuseppe; Capobianchi, Maria Rosaria; Castilletti, Concetta.
Afiliación
  • Colavita F; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Meschi S; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Gruber CEM; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Rueca M; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Vairo F; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Matusali G; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Lapa D; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Giombini E; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • De Carli G; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Spaziante M; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Messina F; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Bonfiglio G; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Carletti F; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Lalle E; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Fabeni L; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Berno G; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Puro V; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Bartolini B; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Di Caro A; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Ippolito G; Unicamillus, International Medical University, Roma, Italy.
  • Capobianchi MR; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Castilletti C; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
Front Med (Lausanne) ; 8: 815870, 2021.
Article en En | MEDLINE | ID: mdl-35127770
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Front Med (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Front Med (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: Italia